Fugenbio

Seoul, South Korea Founded: 2005 • Age: 21 yrs
Provider of artificial cultural method of Ceriporia lacerata for active ingredient of CLEPS

About Fugenbio

Fugenbio is a Healthcare company based in Seoul (South Korea) founded in 2005. Provider of artificial cultural method of Ceriporia lacerata for active ingredient of CLEPS. Fugenbio offers products and services including CLEPS® Essence and Cellona. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity in India is (주)퓨젠바이오 (U99999MH1977PLC010754).

Company details

FUGENBIO provider an artificial cultural method of Ceriporia lacerata for the active ingredient of CLEPS. The Ceriporia lacerata is a white-rot fungus which has applications in food and medicine manufacturing. The company uses proprietary technology for the production of active ingredients such as extracellular polysaccharide (EPS); CLEPS for functional ingredients that can be used in the development of medicine and food additives like control of blood sugar and blood pressure, and improvement of liver and immune function, etc.

  • Headquarters Seoul, South Korea
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website fugenbio.com
  • Legal Name (주)퓨젠바이오
  • Date of Incorporation 10 Aug, 1977
  • Jurisdiction Maharashtra, India

Products & Services of Fugenbio

Fugenbio offers a comprehensive portfolio of products and services, including CLEPS® Essence and Cellona.

CLEPS® Essence
Skincare Product

Essence for deep skin penetration and cellular health improvement.

Cellona
Health Supplement

Supplement for blood sugar control and insulin resistance management.

Web traffic of Fugenbio

The website of Fugenbio (fugenbio.com) receives about 3.9K visits a month.

  • Monthly visits
    3.9K

    ▼ 32.6% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Fugenbio

Premium access

Complete news archive for Fugenbio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fugenbio

Fugenbio was founded in 2005.

Fugenbio is headquartered in Seoul, South Korea.

FUGENBIO provider an artificial cultural method of Ceriporia lacerata for the active ingredient of CLEPS. The Ceriporia lacerata is a white-rot fungus which has applications in food and medicine manufacturing. The company uses proprietary technology for the production of active ingredients such as extracellular polysaccharide (EPS); CLEPS for functional ingredients that can be used in the development of medicine and food additives like control of blood sugar and blood pressure, and improvement of liver and immune function, etc.

Fugenbio offers CLEPS® Essence and Cellona.

Fugenbio operates through ,.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available